Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 25
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Sci Rep ; 14(1): 10407, 2024 05 06.
Article de Anglais | MEDLINE | ID: mdl-38710792

RÉSUMÉ

Glucose regulated protein 78 (GRP78) is a chaperone protein that is a central mediator of the unfolded protein response, a key cellular stress response pathway. GRP78 has been shown to be critically required for infection and replication of a number of flaviviruses, and to interact with both non-structural (NS) and structural flavivirus proteins. However, the nature of the specific interaction between GRP78 and viral proteins remains largely unknown. This study aimed to characterize the binding domain and critical amino acid residues that mediate the interaction of GRP78 to ZIKV E and NS1 proteins. Recombinant EGFP fused GRP78 and individual subdomains (the nucleotide binding domain (NBD) and the substrate binding domain (SBD)) were used as a bait protein and co-expressed with full length or truncated ZIKV E and NS1 proteins in HEK293T/17 cells. Protein-protein interactions were determined by a co-immunoprecipitation assay. From the results, both the NBD and the SBD of GRP78 were crucial for an effective interaction. Single amino acid substitutions in the SBD showed that R492E and T518A mutants significantly reduced the binding affinity of GRP78 to ZIKV E and NS1 proteins. Notably, the interaction of GRP78 with ZIKV E was stably maintained against various single amino acid substitutions on ZIKV E domain III and with all truncated ZIKV E and NS1 proteins. Collectively, the results suggest that the principal binding between GRP78 and viral proteins is mainly a classic canonical chaperone protein-client interaction. The blocking of GRP78 chaperone function effectively inhibited ZIKV infection and replication in neuronal progenitor cells. Our findings reveal that GRP78 is a potential host target for anti-ZIKV therapeutics.


Sujet(s)
Chaperonne BiP du réticulum endoplasmique , Protéines du choc thermique , Liaison aux protéines , Protéines virales non structurales , Virus Zika , Chaperonne BiP du réticulum endoplasmique/métabolisme , Virus Zika/métabolisme , Virus Zika/physiologie , Humains , Protéines virales non structurales/métabolisme , Protéines virales non structurales/génétique , Protéines du choc thermique/métabolisme , Protéines du choc thermique/génétique , Cellules HEK293 , Protéines de l'enveloppe virale/métabolisme , Protéines de l'enveloppe virale/génétique , Infection par le virus Zika/métabolisme , Infection par le virus Zika/virologie , Réplication virale
2.
Sci Rep ; 14(1): 8355, 2024 04 09.
Article de Anglais | MEDLINE | ID: mdl-38594438

RÉSUMÉ

Infections with dengue virus (DENV) remain a worldwide public health problem. A number of bona fide cellular targets of DENV have been identified including liver cells. Despite the many lines of evidence confirming the involvement of hepatocytes during DENV infection, only a few studies have used proteomic analysis to understand the modulation of the cellular proteome occurring upon DENV infection. We utilized a 2D-gel electrophoresis analysis to identify proteins that were differentially regulated by DENV 2 infection of liver (Hep3B) cells at 12 h post infection (hpi) and at 48 hpi. The analysis identifies 4 proteins differentially expressed at 12 hpi, and 14 differentially regulated at 48 hpi. One candidate protein identified as downregulated at 48 hpi in the proteomic analysis (GAPDH) was validated in western blotting in Hep3B cells, and subsequently in induced pluripotent stem cell (iPSC) derived human hepatocytes. The reduced expression of GAPDH was coupled with an increase in NADH, and a significantly reduced NAD + /NADH ratio, strongly suggesting that glycolysis is down regulated in response to DENV 2 infection. Metformin, a well characterized drug used in the treatment of diabetes mellitus, is an inhibitor of hepatic gluconeogenesis was shown to reduce the level of DENV 2 infection and new virus production. Collectively these results show that although glycolysis is reduced, glucose is still required, possibly for use by the pentose phosphate pathway to generate nucleosides required for viral replication.


Sujet(s)
Virus de la dengue , Dengue , Humains , Virus de la dengue/physiologie , Protéomique , NAD/métabolisme , Hépatocytes/métabolisme , Glycolyse , Foie/métabolisme , Réplication virale , Protéome/métabolisme , Glyceraldehyde 3-phosphate dehydrogenases/métabolisme
3.
Int J Mol Sci ; 24(22)2023 Nov 11.
Article de Anglais | MEDLINE | ID: mdl-38003407

RÉSUMÉ

Zika virus (ZIKV) is a mosquito-transmitted virus that has emerged as a major public health concern due to its association with neurological disorders in humans, including microcephaly in fetuses. ZIKV infection has been shown to alter the miRNA profile in host cells, and these changes can contain elements that are proviral, while others can be antiviral in action. In this study, the expression of 22 miRNAs in human A549 cells infected with two different ZIKV isolates was investigated. All of the investigated miRNAs showed significant changes in expression at at least one time point examined. Markedly, 18 of the miRNAs examined showed statistically significant differences in expression between the two strains examined. Four miRNAs (miR-21, miR-34a, miR-128 and miR-155) were subsequently selected for further investigation. These four miRNAs were shown to modulate antiviral effects against ZIKV, as downregulation of their expression through anti-miRNA oligonucleotides resulted in increased virus production, whereas their overexpression through miRNA mimics reduced virus production. However, statistically significant changes were again seen when comparing the two strains investigated. Lastly, candidate targets of the miRNAs miR-34a and miR-128 were examined at the level of the mRNA and protein. HSP70 was identified as a target of miR-34a, but, again, the effects were strain type-specific. The two ZIKV strains used in this study differ by only nine amino acids, and the results highlight that consideration must be given to strain type variation when examining the roles of miRNAs in ZIKV, and probably other virus infections.


Sujet(s)
microARN , Infection par le virus Zika , Virus Zika , Animaux , Humains , Virus Zika/physiologie , microARN/métabolisme , Régulation négative , Antiviraux/pharmacologie , Réplication virale
4.
BMC Res Notes ; 16(1): 296, 2023 Oct 27.
Article de Anglais | MEDLINE | ID: mdl-37891687

RÉSUMÉ

OBJECTIVE: Studies have shown that Flavivirus infection remodels the host cell to favour viral replication. In particular, the host cell lipid profile is altered, and it has been proposed that this process alters membrane fluidity to allow wrapping of the outer structural proteins around the viral nucleocapsid. We investigated whether expression of the Zika virus (ZIKV) and dengue virus (DENV) protease induced alterations in the cellular lipid profile, and subsequently whether co-expression of these proteases with VLP constructs was able to improve VLP yield. RESULTS: Our results showed that both ZIKV and DENV proteases induced alterations in the lipid profile, but that both active and inactive proteases induced many of the same changes. Neither co-transfection of protease and VLP constructs nor bicistronic vectors allowing expression of both protease and VLP separated by a cell cleavable linker improved VLP yield, and indeed many of the constructs showed significantly reduced VLP production. Further work in developing improved VLP expression platforms is required.


Sujet(s)
Virus de la dengue , Infection par le virus Zika , Virus Zika , Humains , Virus Zika/génétique , Virus de la dengue/génétique , Protéines virales non structurales/génétique , Peptide hydrolases , Lipides
5.
PLoS One ; 18(10): e0293010, 2023.
Article de Anglais | MEDLINE | ID: mdl-37847693

RÉSUMÉ

Vitamin D has been shown to have antiviral activity in a number of different systems. However, few studies have investigated whether the antiviral activity is exerted through the vitamin D receptor (VDR). In this study, we investigated whether the antiviral activity of a vitamin D receptor agonist (EB1089) towards dengue virus (DENV) was modulated by VDR. To undertake this, VDR was successively overexpressed, knocked down and retargeted through mutation of the nuclear localization signal. In no case was an effect seen on the level of the antiviral activity induced by EB1089, strongly indicating that the antiviral activity of EB1089 is not exerted through VDR. To further explore the antiviral activity of EB1089 in a more biologically relevant system, human neural progenitor cells were differentiated from induced pluripotent stem cells, and infected with Zika virus (ZIKV). EB1089 exerted a significant antiviral effect, reducing virus titers by some 2Log10. In support of the results seen with DENV, no expression of VDR at the protein level was observed. Collectively, these results show that the vitamin D receptor agonist EB1089 exerts its antiviral activity independently of VDR.


Sujet(s)
Infection par le virus Zika , Virus Zika , Humains , Récepteur calcitriol/génétique , Récepteur calcitriol/métabolisme , Virus Zika/métabolisme , Vitamine D/pharmacologie , Antiviraux/pharmacologie
6.
PLoS Negl Trop Dis ; 17(10): e0011422, 2023 Oct.
Article de Anglais | MEDLINE | ID: mdl-37856569

RÉSUMÉ

Japanese encephalitis virus (JEV) continues to circulate throughout Southeast Asia and the Western Pacific where approximately 3 billion people in 24 countries are at risk of infection. Surveillance targeting the mosquito vectors of JEV was conducted at four military installations on Okinawa, Japan, between 2016 and 2021. Out of a total of 10,426 mosquitoes from 20 different species, zero were positive for JEV. The most abundant mosquito species collected were Aedes albopictus (36.4%) followed by Culex sitiens (24.3%) and Armigeres subalbatus (19%). Statistically significant differences in mosquito species populations according to location were observed. Changes in land use over time appear to be correlated with the species and number of mosquitoes trapped in each location. JEV appears to be absent from mosquito populations on Okinawa, but further research on domestic pigs and ardeid birds is warranted.


Sujet(s)
Aedes , Culex , Virus de l'encéphalite japonaise (espèce) , Encéphalite japonaise , Personnel militaire , Humains , Animaux , Suidae , Encéphalite japonaise/diagnostic , Encéphalite japonaise/épidémiologie , Encéphalite japonaise/médecine vétérinaire , Sus scrofa , Vecteurs moustiques
7.
Viruses ; 14(11)2022 11 19.
Article de Anglais | MEDLINE | ID: mdl-36423175

RÉSUMÉ

A lipid bilayer produced from the host membrane makes up around 20% of the weight of the dengue virus (DENV) virion and is crucial for virus entry. Despite its significance, the virion's lipid composition is still poorly understood. In tandem with lipid profiles of the cells utilised to generate the virions, this work determined a partial lipid profile of DENV virions derived from two cell lines (C6/36 and LLC-MK2). The results showed distinctive profiles between the two cell types. In the mammalian LLC-MK2 cells, 30.8% (73/237 identified lipid species; 31 upregulated, 42 downregulated) of lipid species were altered in response to infection, whilst in insect C6/36 cells only 12.0% (25/208; 19 upregulated, 6 downregulated) of lipid species showed alterations in response to infection. For virions from LLC-MK2 cells, 14 lipids were detected specifically in virions with a further seven lipids being enriched (over mock controls). For virions from C6/36 cells, 43 lipids were detected that were not seen in mock preparations, with a further 16 being specifically enriched (over mock control). These results provide the first lipid description of DENV virions produced in mammalian and mosquito cells, as well as the lipid changes in the corresponding infected cells.


Sujet(s)
Culicidae , Virus de la dengue , Animaux , Virus de la dengue/physiologie , Virion/métabolisme , Lignée cellulaire , Double couche lipidique/métabolisme , Mammifères
8.
Brain Res Bull ; 170: 29-38, 2021 05.
Article de Anglais | MEDLINE | ID: mdl-33556560

RÉSUMÉ

Mis-functional ßAPP processing is deemed to be the major phenomenon resulting in increased neuronal cell death, impaired neurogenesis and the loss of synapses, which eventually manifest as the complex symptoms of Alzheimer's disease. Despite of several milestones having been achieved in the field of drug development, the stigma of the disorder as an incurable disease still remains. Some ADAM proteases mediate the physiological non-amyloidogenic α-secretase processing of ßAPP that generates neuroprotective sAPPα production. Earlier studies have also pointed out the role of p53 in Alzheimer's disease neuropathology, although a direct link with metalloprotease activities remains to be established. In this study, we explored the consequences of α-secretase inhibition on p53 status in cultured human neuroblastoma SH-SY5Y cells by means of specific inhibitors of ADAM10 and ADAM17 and the metal chelator and general metalloprotease inhibitor phenanthroline. We establish that, beyond the ability of all inhibitors to affect sAPPα production to varying degrees, phenanthroline specifically and dose-dependently lessened ßAPP expression, a phenomenon that correlated with a strong increase in p53 protein levels and a concomitant decrease of the p53-degrading calpain protease. Furthermore, treatment of cells at concentrations of phenanthroline similar to those inducing increased levels of p53 induced cell cycle arrest leading to apoptosis. Altogether, our results identify new roles of phenanthroline in perturbing ßAPP, p53 and calpain biology, and suggest that the use of this compound and its derivatives as antimicrobial and anti-cancer therapies might trigger Alzheimer's disease pathogenesis.


Sujet(s)
Précurseur de la protéine bêta-amyloïde/métabolisme , Points de contrôle du cycle cellulaire/effets des médicaments et des substances chimiques , Phénanthrolines/pharmacologie , Protéine p53 suppresseur de tumeur/métabolisme , Protéine ADAM10/métabolisme , Amyloid precursor protein secretases/métabolisme , Précurseur de la protéine bêta-amyloïde/génétique , Lignée cellulaire tumorale , Expression des gènes/effets des médicaments et des substances chimiques , Humains , Neuroblastome/métabolisme , Neuroblastome/anatomopathologie
9.
Sci Rep ; 11(1): 393, 2021 01 11.
Article de Anglais | MEDLINE | ID: mdl-33432092

RÉSUMÉ

Zika virus (ZIKV) is a mosquito-transmitted virus that has caused significant public health concerns around the world, partly because of an association with microcephaly in babies born to mothers who were infected with ZIKV during pregnancy. As a recently emerging virus, little is known as to how the virus interacts with the host cell machinery. A yeast-2-hybrid screen for proteins capable of interacting with the ZIKV E protein domain III, the domain responsible for receptor binding, identified 21 proteins, one of which was the predominantly ER resident chaperone protein GRP78. The interaction of GRP78 and ZIKV E was confirmed by co-immunoprecipitation and reciprocal co-immunoprecipitation, and indirect immunofluorescence staining showed intracellular and extracellular co-localization between GRP78 and ZIKV E. Antibodies directed against the N-terminus of GRP78 were able to inhibit ZIKV entry to host cells, resulting in significant reductions in the levels of ZIKV infection and viral production. Consistently, these reductions were also observed after down-regulation of GRP78 by siRNA. These results indicate that GRP78 can play a role mediating ZIKV binding, internalization and replication in cells. GRP78 is a main regulator of the unfolded protein response (UPR), and the study showed that expression of GRP78 was up-regulated, and the UPR was activated. Increases in CHOP expression, and activation of caspases 7 and 9 were also shown in response to ZIKV infection. Overall these results indicate that the interaction between GRP78 and ZIKV E protein plays an important role in ZIKV infection and replication, and may be a potential therapeutic target.


Sujet(s)
Protéines du choc thermique/métabolisme , Protéines virales structurales/métabolisme , Virus Zika/métabolisme , Cellules A549 , Adulte , Sujet âgé , Animaux , Cellules cultivées , Chlorocebus aethiops , Culicidae , Chaperonne BiP du réticulum endoplasmique , Protéines du choc thermique/physiologie , Interactions hôte-pathogène , Humains , Mâle , Adulte d'âge moyen , Liaison aux protéines , Cellules Vero , Pénétration virale , Virus Zika/physiologie , Infection par le virus Zika/métabolisme , Infection par le virus Zika/virologie
10.
Methods Mol Biol ; 2183: 183-203, 2021.
Article de Anglais | MEDLINE | ID: mdl-32959245

RÉSUMÉ

Zika virus (ZIKV) is a mosquito-transmitted virus that has caused major outbreaks of disease around the world over the last few years. The infectious ZIKV consists of a structural protein outer shell surrounding a nucleocapsid. Virus-like particles (VLP) consist of the outer structural protein shell, but without the nucleocapsid, and are hence noninfectious. VLP, however, are structurally equivalent to the native virus and thus present a similar antigenic profile. These properties make them good candidates for vaccine development. ZIKV VLP can be generated on a laboratory scale by cloning the relevant structural proteins into a eukaryotic expression vector and transfecting the construct into mammalian cells. The secreted VLP can be harvested from the culture medium and purified by sucrose cushion ultracentrifugation. Validation of the VLP is achieved through western blotting and electron microscopy.


Sujet(s)
Techniques de culture cellulaire en batch , Vaccins à pseudo-particules virales/biosynthèse , Vaccins à pseudo-particules virales/immunologie , Virus Zika/immunologie , Techniques de culture cellulaire , Clonage moléculaire , Expression des gènes , Génie génétique , Vecteurs génétiques/génétique , Cellules HEK293 , Humains , Plasmides/génétique , Vaccins à pseudo-particules virales/isolement et purification , Vaccins à pseudo-particules virales/ultrastructure
11.
Sci Rep ; 10(1): 10835, 2020 07 02.
Article de Anglais | MEDLINE | ID: mdl-32616772

RÉSUMÉ

Infections with the mosquito-transmitted dengue virus (DENV) are a pressing public health problem in many parts of the world. The recently released commercial vaccine for DENV has encountered some problems, and there is still no effective drug to treat infections. Vitamin D has a well characterized role in calcium and phosphorus homeostasis, but additionally has a role in the immune response to bacterial and viral pathogens. In this study a number of fused bicyclic derivatives of 1H-pyrrolo[1,2]imidazol-1-one with vitamin D receptor (VDR) agonist activity were evaluated for possible anti-DENV activity. The results showed that five of the compounds were able to significantly inhibit DENV infection. The most effective compound, ZD-3, had an EC50 value of 7.47 µM and a selective index of 52.75. The compounds were only effective when used as a post-infection treatment and treatment significantly reduced levels of infection, virus output, DENV protein expression and genome copy number. These results suggest that these VDR agonists have the potential for future development as effective anti-DENV agents.


Sujet(s)
Virus de la dengue/effets des médicaments et des substances chimiques , Dengue/traitement médicamenteux , Imidazoles/pharmacologie , Immunosuppresseurs/pharmacologie , Récepteur calcitriol/agonistes , Réplication virale/effets des médicaments et des substances chimiques , Calcitriol/analogues et dérivés , Calcitriol/pharmacologie , Cellules cultivées , Dengue/métabolisme , Dengue/virologie , Humains
12.
Molecules ; 25(5)2020 Mar 10.
Article de Anglais | MEDLINE | ID: mdl-32164193

RÉSUMÉ

Kaempferol, a plant-derived flavonoid, has been reported to have activity against Japanese encephalitis virus (JEV) in BHK-21 cells. To determine the broader utility of this compound, we initially evaluated the activity of kaempferol against JEV and dengue virus (DENV) in HEK293T/17 cells. Results showed no significant antiviral activity against either virus. We subsequently investigated the activity of kaempferol against both JEV and DENV in BHK-21 cells. Results showed a significant inhibition of JEV infection but, surprisingly, a significant enhancement of DENV infection. The effect of kaempferol on both host protein expression and transcription was investigated and both transcriptional and translational inhibitory effects were observed, although a more marked effect was observed on host cell protein expression. Markedly, while GRP78 was increased in DENV infected cells treated with kaempferol, it was not increased in JEV infected cells treated with kaempferol. These results show that cellular alteration induced by one compound can have opposite effects on viruses from the same family, suggesting the presence of distinct replication strategies for these two viruses.


Sujet(s)
Virus de la dengue/effets des médicaments et des substances chimiques , Virus de l'encéphalite japonaise (espèce)/effets des médicaments et des substances chimiques , Kaempférols/pharmacologie , Animaux , Lignée cellulaire , Cricetinae , Dengue/traitement médicamenteux , Dengue/génétique , Encéphalite japonaise/traitement médicamenteux , Encéphalite japonaise/génétique , Chaperonne BiP du réticulum endoplasmique , Cellules HEK293 , Protéines du choc thermique/génétique , Humains , Biosynthèse des protéines/effets des médicaments et des substances chimiques , Transcription génétique/effets des médicaments et des substances chimiques , Réplication virale/effets des médicaments et des substances chimiques
13.
Chem Biol Interact ; 319: 109021, 2020 Mar 01.
Article de Anglais | MEDLINE | ID: mdl-32092301

RÉSUMÉ

High dietary iron intake is a risk factor for the development of colorectal cancer. However, how iron subsequently impacts the proliferation of colorectal cancer cells remains unclear. This study determined the expression of six iron regulatory genes in twenty-one human colorectal cancer (CRC) biopsies and matched normal colonic tissue. The results show that only hepcidin and ferritin heavy chain expression were increased in CRC biopsies as compared to matched normal tissues. Four established human CRC cell lines, HT-29, HCT-116, SW-620 and SW-480 were subsequently examined for their growth in response to increasing concentrations of iron, and iron depletion. Real time cell growth assay showed a significant inhibitory effect of acute iron loading in HCT-116 cells (IC50 = 258.25 µM at 72 h), and no significant effects in other cell types. However, ten week treatment with iron significantly reduced HT-29 and SW-620 cell growth, whereas no effect was seen in HCT-116 and SW-480 cells. Intracellular labile iron depletion induced the complete growth arrest and detachment of all of the CRC cell types except for the SW-620 cell line which was not affected in its growth. Treatment of starved CRC cells with hepcidin, the major regulator of iron metabolism, induced a significant stimulation of HT-29 cell growth but did not affect the growth of the other cell types. Collectively these results show that iron is central to CRC cell growth in a manner that is not identical between acute and chronic loading, and that is specific to the CRC cell type.


Sujet(s)
Prolifération cellulaire/effets des médicaments et des substances chimiques , Tumeurs colorectales/traitement médicamenteux , Hepcidines/pharmacologie , Fer alimentaire/pharmacologie , Fer/pharmacologie , Lignée cellulaire tumorale , Cellules HCT116 , Cellules HT29 , Humains
14.
J Infect Public Health ; 13(1): 11-15, 2020 Jan.
Article de Anglais | MEDLINE | ID: mdl-31669035

RÉSUMÉ

Zika virus (ZIKV), a mosquito transmitted virus in the family Flaviviridae, genus Flavivirus, recently emerged to cause infections in more than 70 countries and territories around the world. While human infection is normally asymptomatic, it can also result in a mild febrile disease similar to dengue fever. However, when a pregnant woman is infected, ZIKV can cause fetal abnormalities including microcephaly. Evidence has suggested that ZIKV has circulated in Southeast Asia for more than a decade and yet cases of ZIKV associated microcephaly remain sparsely documented. This review seeks to collate the information currently existing on ZIKV associated microcephaly in Southeast Asia, and assess the potential future risk posed by this virus.


Sujet(s)
Microcéphalie/épidémiologie , Microcéphalie/virologie , Infection par le virus Zika/complications , Infection par le virus Zika/épidémiologie , Asie du Sud-Est/épidémiologie , Épidémies de maladies/prévention et contrôle , Épidémies de maladies/statistiques et données numériques , Femelle , Santé mondiale , Humains , Transmission verticale de maladie infectieuse/prévention et contrôle , Transmission verticale de maladie infectieuse/statistiques et données numériques , Grossesse , Femmes enceintes , Virus Zika
15.
Sci Rep ; 9(1): 13498, 2019 09 18.
Article de Anglais | MEDLINE | ID: mdl-31534148

RÉSUMÉ

Despite the widespread presence of the mosquito transmitted Zika virus (ZIKV) over much of Southeast Asia, the number of reported cases remains low. One possibility is that residents in Southeast Asia are immunologically protected, although the nature of any such protection remains unclear. This study sought to investigate the presence of antibodies directed to ZIKV NS1 protein in a selected sub-set of samples from a well characterized cohort of serum samples from normal, healthy Thais that had been previously characterized for the presence of neutralizing antibodies to ZIKV, DENV 1-4, and JEV. Because of similarities in molecular weight between the flavivirus E and NS1 proteins, an immunoblot system was established in which the NS1 antigen was not denatured, allowing detection of the dimer form of NS1, distinctly clear from the migration position of the E and NS1 monomer proteins. The results showed that antibodies to ZIKV NS1 protein were only detected in samples with ZIKV neutralizing antibodies (27/30 samples), and no sample (0/30) with a ZIKV plaque reduction neutralization test (PRNT)90 < 20 showed evidence of anti-ZIKV NS1 antibodies. The high correlation between the presence of ZIKV NS1 antibodies and ZIKV PRNT suggests that immunological protection against ZIKV infection in Thailand arises from prior exposure to ZIKV, and not through cross neutralization.


Sujet(s)
Anticorps neutralisants , Anticorps antiviraux , Protéines virales non structurales , Virus Zika/immunologie , Animaux , Anticorps neutralisants/sang , Anticorps neutralisants/immunologie , Anticorps antiviraux/sang , Anticorps antiviraux/immunologie , Lignée cellulaire , Cricetinae , Femelle , Humains , Mâle , Thaïlande , Protéines virales non structurales/sang , Protéines virales non structurales/immunologie , Infection par le virus Zika/sang , Infection par le virus Zika/immunologie
16.
Sci Rep ; 8(1): 17193, 2018 11 21.
Article de Anglais | MEDLINE | ID: mdl-30464242

RÉSUMÉ

Zika virus (ZIKV) infections have been reported from all over Thailand, but the number of reported cases remains low, suggesting a degree of immune protection against ZIKV infection. To address this possibility, the presence of ZIKV neutralizing antibodies was determined in serum from 135 healthy Thai adults with a plaque reduction neutralization test (PRNT), and a number of samples were subsequently analyzed for the presence of neutralizing antibodies to dengue virus (DENV) and Japanese encephalitis virus (JEV). Results showed that 70.4% (PRNT50 ≥ 10), 55.6 (PRNT50 ≥ 20) or 22.2% (PRNT90 ≥ 20) of the samples showed neutralizing antibodies to ZIKV. Detailed analysis showed no association between the presence of neutralizing antibodies to other flaviviruses (DENV, JEV) and the presence of ZIKV neutralizing antibodies. These results suggest that the level of ZIKV neutralizing antibodies in the Thai population is enough to dampen the transmission of the virus in Thailand.


Sujet(s)
Anticorps neutralisants/sang , Anticorps antiviraux/sang , Volontaires sains , Virus Zika/immunologie , Adulte , Virus de la dengue/immunologie , Virus de l'encéphalite japonaise (espèce)/immunologie , Femelle , Humains , Mâle , Adulte d'âge moyen , Tests de neutralisation , Études séroépidémiologiques , Thaïlande , Jeune adulte
17.
Hematology ; 23(7): 423-428, 2018 Aug.
Article de Anglais | MEDLINE | ID: mdl-29157161

RÉSUMÉ

OBJECTIVES: The inherited genetic disorder beta0-thalassemia/Hb E disease is associated with the over-suppression of the master regulator of iron homeostasis, the peptide hormone hepcidin. How developing erythroid cells mediate the suppression of hepcidin remains controversial, although a number of inhibitors have been proposed. METHODS: To investigate the ability of erythroid cells to suppress hepcidin expression in liver cells, conditioned media from the culture of in vitro differentiating erythroblasts (from normal controls and beta0-thalassemia/Hb E patients) was used to treat HepG2 cells, and the effects on hepcidin expression were assayed by real-time quantitative PCR and confocal microscopy. RESULTS: Early activation followed by later suppression of hepcidin expression was seen posttreatment. Markedly, however, no significant differences were observed between suppression of hepcidin as mediated by media from the culture of erythroblasts from normal controls and beta0-thalassemia/Hb E patients Discussion: Previous studies investigating the suppression of hepcidin expression in beta0-thalassemia/Hb E disease have used patient-derived serum samples, which are complex fluids with contributions from multiple cell types. This study has developed a simple in vitro system that allows investigation of how a single cell type mediates hepcidin expression. The results support proposals that over-suppression of hepcidin seen in beta-thalassemia/Hb E patients is a consequence of the increased mass of erythropoiesis and not defects in the signaling process per se. CONCLUSION: The in vitro cell system developed here allows further investigation into the processes mediating erythroid cell suppression of liver hepcidin expression in both normal and pathological states.


Sujet(s)
Érythroblastes/métabolisme , Régulation de l'expression des gènes , Hémoglobine E/génétique , Hepcidines/génétique , bêta-Thalassémie/sang , bêta-Thalassémie/génétique , Lignée cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Milieux de culture conditionnés/pharmacologie , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Cellules souches hématopoïétiques/cytologie , Cellules souches hématopoïétiques/métabolisme , Cellules HepG2 , Humains
18.
Sci Rep ; 7(1): 9194, 2017 08 23.
Article de Anglais | MEDLINE | ID: mdl-28835669

RÉSUMÉ

Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor frequently used in combination with other antiretroviral agents for highly active antiretroviral therapy (HAART) of patients infected with the human immunodeficiency virus type 1 (HIV-1). However NVP can cause serious, life-threatening complications. Hepatotoxicity is one of the most severe adverse effects, particularly in HIV patients with chronic hepatitis C virus co-infection as these patients can develop liver toxicity after a relatively short course of treatment. However, the mechanism of NVP-associated hepatotoxicity remains unclear. This study sought to investigate the effect of NVP on protein expression in liver cells using a proteomic approach. HepG2 cells were treated or not treated with NVP and proteins were subsequently resolved by two-dimensional gel electrophoresis. A total of 33 differentially regulated proteins were identified, of which nearly 40% (13/33) were mitochondrial proteins. While no obvious differences were observed between NVP treated and untreated cells after staining mitochondria with mitotracker, RT-PCR expression analysis of three mitochondrially encoded genes showed all were significantly up-regulated in NVP treated cells. Mitochondrial dysfunction was observed in response to treatment even with slightly sub-optimal therapeutic treatment concentrations of NVP. This study shows that NVP induces mitochondrial dysregulation in HepG2 cells.


Sujet(s)
Agents antiVIH/pharmacologie , Mitochondries/effets des médicaments et des substances chimiques , Mitochondries/métabolisme , Névirapine/pharmacologie , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Gènes de mitochondrie , Cellules HepG2 , Humains , Mitochondries/génétique , Mitochondries du foie/effets des médicaments et des substances chimiques , Mitochondries du foie/génétique , Mitochondries du foie/métabolisme , Protéome , Protéomique/méthodes
19.
Int J Biol Macromol ; 94(Pt A): 728-734, 2017 Jan.
Article de Anglais | MEDLINE | ID: mdl-27765567

RÉSUMÉ

Ribosome biogenesis is the process of synthesis of the cellular ribosomes which mediate protein translation. Integral with the ribosomes are four cytoplasmic ribosomal RNAs (rRNAs) which show extensive post-transcriptional modifications including 2'-O-methylation and pseudouridylation. Several hereditary hematologic diseases including Diamond-Blackfan anemia have been shown to be associated with defects in ribosome biogenesis. Thalassemia is the most important hematologic inherited genetic disease worldwide, and this study examined the post-transcriptional ribose methylation status of three specific active sites of the 28S rRNA molecule at positions 1858, 4197 and 4506 of ß-thalassemia trait carriers and normal controls. Samples from whole blood and cultured erythroid cells were examined. Results showed that site 4506 was hypermethylated in ß-thalassemia trait carriers in both cohorts. Expression of fibrillarin, the ribosomal RNA methyltransferase as well as snoRNAs were additionally quantified by RT-qPCR and evidence of dysregulation was seen. Hemoglobin E trait carriers also showed evidence of dysregulation. These results provide the first evidence that ribosome biogenesis is dysregulated in ß-thalassemia trait carriers.


Sujet(s)
Protéines chromosomiques nonhistones/métabolisme , Hémoglobine E/métabolisme , Maturation post-transcriptionnelle des ARN , ARN ribosomique 28S/métabolisme , Ribosomes/métabolisme , bêta-Thalassémie/métabolisme , Études cas-témoins , Protéines chromosomiques nonhistones/génétique , Expression des gènes , Cellules souches hématopoïétiques/métabolisme , Cellules souches hématopoïétiques/anatomopathologie , Hémoglobine E/génétique , Hétérozygote , Humains , Agranulocytes/métabolisme , Agranulocytes/anatomopathologie , Méthylation , Culture de cellules primaires , Biosynthèse des protéines , ARN ribosomique 28S/génétique , Petit ARN nucléolaire/génétique , Petit ARN nucléolaire/métabolisme , Ribosomes/génétique , Uridine monophosphate/génétique , Uridine monophosphate/métabolisme , bêta-Thalassémie/génétique , bêta-Thalassémie/anatomopathologie
20.
Asian Pac J Trop Med ; 9(11): 1035-1043, 2016 11.
Article de Anglais | MEDLINE | ID: mdl-27890361

RÉSUMÉ

Iron deficiency anemia and iron overload conditions affect more than one billion people worldwide. Iron homeostasis involves the regulation of cells that export iron into the plasma and cells that utilize or store iron. The cellular iron balance in humans is primarily mediated by the hepcidin-ferroportin axis. Ferroportin is the sole cellular iron export protein, and its expression is regulated transcriptionally, post-transcriptionally and post-translationally. Hepcidin, a hormone produced by liver cells, post-translationally regulates ferroportin expression on iron exporting cells by binding with ferroportin and promoting its internalization by endocytosis and subsequent degradation by lysosomes. Dysregulation of iron homeostasis leading to iron deposition in vital organs is the main cause of death in beta-thalassemia patients. Beta-thalassemia patients show marked hepcidin suppression, ineffective erythropoiesis, anemia and iron overload. Beta-thalassemia is common in the Mediterranean region, Southeast Asia and the Indian subcontinent, and the focus of this review is to provide an update on the factors mediating hepcidin related iron dysregulation in beta-thalassemia disease. Understanding this process may pave the way for new treatments to ameliorate iron overloading and improve the long term prognosis of these patients.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...